ZIM Laboratories Limited (BOM:541400)

Market Cap	5.88B
Revenue (ttm)	3.79B
Net Income (ttm)	121.65M
Shares Out	48.73M
EPS (ttm)	2.50
PE Ratio	48.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,307
Average Volume	13,283
Open	113.80
Previous Close	113.55
Day's Range	113.00 - 115.25
52-Week Range	79.50 - 128.45
Beta	0.58
RSI	70.21
Earnings Date	Aug 8, 2025

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and ...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 577
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 541400

Financial Performance

In 2024, ZIM Laboratories's revenue was 3.79 billion, an increase of 3.16% compared to the previous year's 3.68 billion. Earnings were 121.65 million, a decrease of -29.46%.